GSK to drive growth in emerging markets with acquisition of UCB products
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Novartis launches Extavia®, the standard-of-care for relapsing forms of multiple sclerosis
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Foundation-laying ceremony for new R&D building at Roche Basel
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Amgen's Breakaway from Cancer Initiative Expands to Help Cancer Patients
- Details
- Category: Amgen
![Amgen Amgen](http://www.worldpharmanews.com/images/stories/logo/amgen.gif)
Four innovative Novartis medicines approved in Japan
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
More Pharma News ...
- Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results
- New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available
- Pfizer Receives FDA Complete Response Letter for Lasofoxifene
- US Department of Health and Human Services awards Novartis USD 486 million contract
- Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
- Nycomed strengthens its osteoporosis portfolio
- U.S. FDA Issues Complete Response Letter for SAPHRIS(TM)